Top mRNA therapeutics companies by Market Cap
Browse the largest mRNA therapeutics companies in the world ranked by their Market Capitalization. Global mRNA therapeutics Companies market cap is $455.10B.
20 Nov 2024, 06:59 UTC
Companies: 68
🇺🇸1 |  | $29.74 | -0.03% | 167.92B | 2.98% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸2 |  | $474.16 | -1.48% | 122.19B | 17.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵3 |  | $29.61 | -0.05% | 45.94B | 2.26% | Underperform S&P500 YTD Benchamark | 💊 Pharma | 4.28% |
🇩🇪4 |  | $115.55 | -7.41% | 27.47B | 9.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸5 |  | $69.86 | -2.96% | 26.64B | -30.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸6 |  | $125.01 | -0.54% | 11.69B | 30.90% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇰7 |  | $148.75 | 1.47% | 8.37B | 20.40% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $42.36 | 2.05% | 6.08B | -17.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇭9 |  | $49.59 | -0.56% | 3.94B | -19.81% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸10 |  | $16.00 | 0.00% | 3.30B | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸11 |  | $42.11 | 2.11% | 2.30B | 7.20% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳12 |  | $1.40 | -0.90% | 2.24B | -57.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸13 |  | $20.78 | 3.85% | 2.22B | -31.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵14 |  | $17.02 | 0.75% | 2.21B | 63.38% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸15 |  | $25.50 | -0.31% | 2.08B | -5.38% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸16 |  | $22.52 | -0.13% | 2.02B | -25.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇧🇪17 |  | $30.39 | -1.30% | 2.00B | -26.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸18 |  | $20.85 | -0.90% | 1.27B | -1.51% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸19 |  | $9.21 | 0.77% | 1.22B | 40.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳20 |  | $3.42 | -4.82% | 1.21B | -61.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸21 |  | $18.07 | -0.66% | 1.19B | 81.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸22 |  | $9.05 | 3.31% | 1.04B | 105.68% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳23 |  | $2.88 | 1.13% | 920.13M | 7.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸24 |  | $8.52 | 0.12% | 868.38M | 1451.91% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸25 |  | $3.52 | -2.00% | 764.77M | 1492.76% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇪26 |  | $3.29 | 0.30% | 736.71M | -22.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧27 |  | $18.26 | 0.16% | 706.11M | 3.75% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸28 |  | $21.55 | 4.56% | 575.89M | -31.76% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷29 |  | $12.02 | 0.82% | 540.28M | -2.92% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸30 |  | $2.15 | -1.38% | 401.96M | 25.73% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳31 |  | $1.14 | 0.00% | 360.98M | -18.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇹🇼32 |  | $0.46 | 1.04% | 326.81M | -4.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸33 |  | $3.87 | 1.04% | 316.08M | -61.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳34 |  | $3.25 | -2.54% | 299.48M | -44.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳35 |  | $4.25 | 1.41% | 298.51M | -45.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸36 |  | $36.73 | -1.45% | 294.26M | -22.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳37 |  | $0.55 | -3.36% | 272.15M | -46.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸38 |  | $3.93 | -1.75% | 247.06M | 22.05% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸39 |  | $9.26 | 1.54% | 220.51M | 36.58% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸40 |  | $2.08 | -0.95% | 183.94M | -63.57% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷41 |  | $2.31 | -0.72% | 165.14M | -25.95% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦42 |  | $6.94 | 2.21% | 160.99M | -19.68% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸43 |  | $5.12 | 0.79% | 157.66M | 4.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷44 |  | $1.82 | -6.94% | 142.48M | -14.66% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸45 |  | $5.46 | 2.44% | 135.26M | 10.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳46 |  | $3.27 | -2.61% | 130.62M | -48.67% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇹🇼47 |  | $2.04 | 0.00% | 101.75M | -2.54% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵48 |  | $1.37 | -1.52% | 95.81M | 2.63% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇪49 |  | $1.45 | 0.69% | 85.38M | -11.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇮🇱50 |  | $1.81 | 0.15% | 65.74M | 1051.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇵🇱51 |  | $3.56 | -0.93% | 59.99M | -29.56% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸52 |  | $0.18 | -11.62% | 56.62M | 28.68% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸53 |  | $3.92 | -2.24% | 40.68M | 284.31% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸54 |  | $0.43 | 2.44% | 37.78M | -90.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷55 |  | $2.36 | 0.81% | 27.04M | 6.51% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧56 |  | $0.02 | -6.20% | 22.00M | -38.17% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺57 |  | $0.07 | 0.00% | 19.75M | 35.14% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇵🇱58 |  | $1.64 | -4.29% | 19.33M | -34.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸59 |  | $3.66 | -0.95% | 16.74M | 401.37% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸60 |  | $1.04 | -0.95% | 12.85M | 126.09% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷61 |  | $1.85 | 0.36% | 11.25M | -64.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦62 |  | $0.08 | 0.00% | 9.82M | 172.11% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸63 |  | $1.41 | -6.62% | 7.63M | -24.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧64 |  | $0.04 | -4.29% | 5.71M | -53.79% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪65 |  | $0.03 | 4.43% | 3.21M | -38.21% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸66 |  | $0.21 | -14.88% | 2.27M | -55.22% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇧🇲67 |  | $0.75 | -1.32% | 1.06M | -77.48% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
